Palisade Bio

-$0.05 (-1.82%) Today
-$0.05 (-1.85%) As of 9:26 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Palisade Bio and other ETFs, options, and stocks.

About PALI

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.

CEO
Thomas M. Hallam
Employees
7
Headquarters
Carlsbad, California
Founded
—

PALI Key Statistics

Market Cap
34.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
213.59K
High Today
$2.75
Low Today
$2.61
Open Price
$2.74
Volume
157.80K
52 Week High
$16.02
52 Week Low
$2.27

PALI Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure